Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
Clinical trial NCT01896973 · TERMINATED
Trial details
- NCT number
- NCT01896973
- Sponsor
- HistoSonics, Inc.
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2016-12-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.